| Literature DB >> 25443285 |
Tariq Ahmed1, David Blum2, Sylvie Burnouf3, Dominique Demeyer4, Valérie Buée-Scherrer2, Rudi D'Hooge1, Luc Buée2, Detlef Balschun5.
Abstract
Cognitive decline, the hallmark of Alzheimer's disease, and accompanying neuropsychiatric symptoms share dysfunctions of synaptic processes as a common cellular pathomechanism. Long-term potentiation has proven to be a sensitive tool for the "diagnosis" of such synaptic dysfunctions. Much less, however, is known about how long-term depression (LTD), an alternative mechanism for the storage of memory, is affected by Alzheimer's disease progression. Here, we demonstrate that impaired late LTD (>3 hours) in THY-Tau22 mice can be rescued by either inhibition of glycogen synthase kinase-3 (GSK3β) activity or by application of the protein-phosphatase 2A agonist selenate. In line with these findings, we observed increased phosphorylation of GSK3β at Y216 and reduced total phosphatase activity in biochemical assays of hippocampal tissue of THY-Tau22 mice. Interestingly, LTD induction and pharmacologic inhibition of GSK3β appeared to downregulate GSK3ß activity via a marked upregulation of phosphorylation at the inhibitory Ser9 residue. Our results point to alterations in phosphorylation and/or dephosphorylation homeostasis as key mechanisms underlying the deficits in LTD and hippocampus-dependent learning found in THY-Tau22 mice.Entities:
Keywords: Alzheimer's disease; CA1-region; Glycogen synthase kinase-3; Hippocampus; LTD; Long-term depression; Okadaic acid; Protein-phosphatase 2A; SB216763; Sodium selenate; Synaptic plasticity; Tauopathy
Mesh:
Substances:
Year: 2014 PMID: 25443285 DOI: 10.1016/j.neurobiolaging.2014.09.015
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673